Latest News & Information

News

Drugs and Biotech

[09/03] Rochester Leads International Effort to Improve Muscular Dystrophy Treatment
[09/03] Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
[09/02] American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling
[09/02] Office of Justice Programs Weekly News Brief
[09/02] Sequenom to Present at Two Financial Conferences in September
[09/02] Marathon Talks Yield Tentative Agreement With North Adams Regional Hospital Nurses
[09/02] Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
[09/02] ECRI Institute, AHRQ, NIH, and Others Address the Interface Between Comparative Effectiveness and Personalized Medicine
[09/02] AloeSafe Hand Sanitizer is Free From Toxic Chemicals
[09/02] Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
[09/02] Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports
[09/02] Novelda AS to Exhibit Nanoscale Impulse Radar at EXPO 2010 in Shanghai, China
[09/02] Canadian Pharmacy Intermediary SaveRxCanada.com Enhances Online Shopping System
[09/02] Ektio Shoes Launches to Take Ankle Sprains Off the Court
[09/02] Orexigen Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave in North America
[09/02] Sigma Life Science Enters Genetically Modified Cell Market
[09/01] Alere Inc. Declares Dividend on its Series B Convertible Perpetual Preferred Stock
[09/01] HeartSine Donates AEDs to Kentucky Schools
[09/01] Botox-maker pays $600M to resolve investigation
[09/01] Pfizer buying FoldRx for undisclosed amount

Back to Main

Associated Press text, photo, graphic, audio and/or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. Neither these AP materials nor any portion thereof may be stored in a computer except for personal and non-commercial use. Users may not download or reproduce a substantial portion of the AP material found on this web site. AP will not be held liable for any delays, inaccuracies, errors or omissions therefrom or in the transmission or delivery of all or any part thereof or for any damages arising from any of the foregoing.

11020 King Street • Suite 215 • Overland Park, Kansas • 66210 • 888.839.8511 • 913.826.6202

Oliver & Reichel, P.A., is a personal injury law firm in Overland Park, Kansas, representing clients in the cities of Kansas City, Topeka, Lawrence, Emporia, Olathe, Lee's Summit, St. Joseph, and throughout Wyandotte County, Johnson County, and Jackson County and in Western Missouri.

FirmSite® by FindLaw, a Thomson Reuters business.